gpcr Latest News

Presentation download from the Structure-Based Drug Design 2012 conference organized by Cambridge Healthtech Institute & Bio-IT World

Event Focus will be Predicting Biological and Kinetic Profiles from Structure

CHI and Bio-IT World's "Structure-Based Design" Conference to be held on June 8-10, 2011 in Cambridge, MA, will feature a new session: New Targets and Drug Modalities

GPCR & Kinase Targets Advances in drug discovery from molecular to clinical 14th - 15th April 2011, Thistle City Barbican, London, UK

Comprising more than 60% of all therapeutic targets, G-protein coupled receptor and kinase targets are arguably the most exciting proteins in pharmacology today. Find out more by attending this key event

Cambridge Healthtech Institute, a premier information provider for the life sciences industry, will host its Eighth International Discovery on Target meeting on November 2-4, 2010 in Boston, Massachusetts.

New Pharmaceuticals market report from Business Insights: "The Future of GPCRs in Drug Discovery: Novel technologies, leading companies, and opportunities for target expansion"

Executives from Heptares Therapeutics (Welwyn Garden City, UK) and O2h (Cambridge, UK) announced today an extension of the agreement under which O2h provides multi-FTE -synthetic chemistry services to support discovery programmes at Heptares.

Otava releases two GPCR-related focused libraries. The libraries have been designed with QSAR using training set. These libraries are proposed for screening in GPCR-associated research and drug development.

GenScript's Ready-to-UseTM frozen cell series is designed to expedite cellular assays.